1T4V image
Deposition Date 2004-04-30
Release Date 2005-03-22
Last Version Date 2024-10-30
Entry Detail
PDB ID:
1T4V
Title:
Crystal Structure Analysis of a novel Oxyguanidine bound to Thrombin
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Hirudo medicinalis (Taxon ID: 6421)
Method Details:
Experimental Method:
Resolution:
2.00 Å
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Prothrombin
Gene (Uniprot):F2
Chain IDs:B (auth: H)
Chain Length:259
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Hirudin IIIA
Chain IDs:C (auth: I)
Chain Length:11
Number of Molecules:1
Biological Source:Hirudo medicinalis
Polymer Type:polypeptide(L)
Molecule:Prothrombin
Gene (Uniprot):F2
Chain IDs:A (auth: L)
Chain Length:26
Number of Molecules:1
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
TYS C TYR O-SULFO-L-TYROSINE
Ligand Molecules
Primary Citation
Oxyguanidines. Part 2: Discovery of a novel orally active thrombin inhibitor through structure-based drug design and parallel synthesis
BIOORG.MED.CHEM.LETT. 14 3727 3731 (2004)
PMID: 15203151 DOI: 10.1016/j.bmcl.2004.05.002

Abstact

Through structure-based drug design and parallel synthesis, we have discovered a novel series of nonpeptidic phenyl-based thrombin inhibitors using oxyguanidines as guanidine bioisosteres. These compounds have been found to be highly potent, highly selective, and orally bioavailable.

Legend

Protein

Chemical

Disease

Primary Citation of related structures